Stockscreener 앱 받기
8.00
8.40%
0.62
시간 외 거래:
8.00
전일 마감가:
$7.38
열려 있는:
$7.43
하루 거래량:
1.56M
Relative Volume:
1.55
시가총액:
$695.97M
수익:
-
순이익/손실:
$-69.31M
주가수익비율:
-6.2992
EPS:
-1.27
순현금흐름:
$-62.80M
1주 성능:
+12.36%
1개월 성능:
+36.52%
6개월 성능:
+101.01%
1년 성능:
+83.07%
1일 변동 폭
$7.3401
$8.055
1주일 범위
$7.0201
$8.055
52주 변동 폭
$2.215
$8.055
Rezolute Inc Stock (RZLT) Company Profile
명칭
Rezolute Inc
전화
650-206-4507
주소
275 SHORELINE DRIVE, SUITE 500, REDWOOD CITY
RZLT을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
RZLT
Rezolute Inc
|
8.00 | 642.03M | 0 | -69.31M | -62.80M | -1.27 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.12 | 101.77B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
573.38 | 60.12B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
452.00 | 59.45B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
750.78 | 44.90B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
341.80 | 35.07B | 3.81B | -644.79M | -669.77M | -6.24 |
Rezolute Inc Stock (RZLT) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-11-05 | 개시 | Wedbush | Outperform |
| 2024-08-27 | 개시 | Guggenheim | Buy |
| 2024-07-17 | 개시 | BTIG Research | Buy |
| 2024-06-04 | 개시 | Craig Hallum | Buy |
| 2024-04-09 | 개시 | Maxim Group | Buy |
| 2022-08-02 | 재개 | Canaccord Genuity | Buy |
| 2022-06-15 | 개시 | Cantor Fitzgerald | Overweight |
| 2021-09-08 | 개시 | ROTH Capital | Buy |
| 2021-05-27 | 개시 | Oppenheimer | Outperform |
| 2021-05-25 | 개시 | H.C. Wainwright | Buy |
모두보기
Rezolute Inc 주식(RZLT)의 최신 뉴스
Rezolute Inc. Forms Double Bottom Pattern — Eyes on Breakout2025 AllTime Highs & Weekly Hot Stock Watchlists - beatles.ru
Has Rezolute Inc. found a price floorWeekly Market Summary & Real-Time Market Sentiment Reports - Newser
Institution Moves: Is Rezolute Inc. backed by strong institutional buyingPortfolio Risk Report & Fast Gain Stock Tips - خودرو بانک
What dividend growth rate does Rezolute Inc. offerEarnings Trend Report & Low Risk High Win Rate Picks - خودرو بانک
Is Rezolute Inc. benefiting from interest rate changesWatch List & Community Consensus Picks - خودرو بانک
Can Rezolute Inc. outperform in the next rallyJuly 2025 Reactions & Risk Controlled Stock Pick Alerts - خودرو بانک
Rezolute’s (RZLT) “Buy” Rating Reiterated at HC Wainwright - Defense World
Brokerages Set Rezolute, Inc. (NASDAQ:RZLT) Price Target at $12.50 - Defense World
Using data models to predict Rezolute Inc. stock movement2025 Top Gainers & Smart Allocation Stock Tips - Newser
How does Rezolute Inc. compare to its peersWeekly Gains Report & Low Risk Profit Maximizing Plans - خودرو بانک
Volume spikes in Rezolute Inc. stock – what they meanQuarterly Growth Report & Community Verified Trade Signals - Newser
Is Rezolute Inc. benefiting from innovation trendsWeekly Stock Analysis & Real-Time Sentiment Analysis - خودرو بانک
Can Rezolute Inc. recover in the next quarterJobs Report & Fast Entry Momentum Trade Alerts - Newser
Short interest data insights for Rezolute Inc.Portfolio Return Summary & Risk Adjusted Buy and Sell Alerts - Newser
Applying sector rotation models to Rezolute Inc.2025 Volatility Report & Daily Oversold Bounce Ideas - Newser
What moving averages say about Rezolute Inc.2025 Top Gainers & Fast Entry Momentum Alerts - Newser
Can Rezolute Inc. hit a new high this monthQuarterly Performance Summary & Technical Entry and Exit Tips - Newser
Will Rezolute Inc. continue its uptrendOptions Play & Verified Momentum Stock Watchlist - Newser
Should value investors consider Rezolute Inc.July 2025 Big Picture & Daily Profit Focused Screening - خودرو بانک
Tools to monitor Rezolute Inc. recovery probabilityQuarterly Trade Report & Technical Pattern Recognition Alerts - Newser
What is Rezolute Inc.’s book value per share2025 Trading Recap & Smart Investment Allocation Insights - خودرو بانک
Rezolute Inc. stock trend outlook and recovery pathJuly 2025 Trends & AI Driven Price Forecasts - Newser
What the charts say about Rezolute Inc. todayWeekly Gains Report & AI Driven Price Forecasts - Newser
Price action breakdown for Rezolute Inc.July 2025 Summary & Accurate Technical Buy Alerts - Newser
Why Rezolute Inc. is moving todayWeekly Trend Report & Safe Capital Growth Stock Tips - Newser
Combining price and volume data for Rezolute Inc.July 2025 Outlook & Weekly Return Optimization Alerts - Newser
Rezolute stock rating reiterated at Buy by H.C. Wainwright on FDA study approval - Investing.com Australia
Trend analysis for Rezolute Inc. this weekGap Down & Reliable Price Breakout Signals - Newser
What chart patterns are forming on Rezolute Inc.July 2025 Rallies & Expert Approved Momentum Ideas - خودرو بانک
Can a trend reversal in Rezolute Inc. lead to recoveryWeekly Trend Report & Free Growth Oriented Trading Recommendations - Newser
Applying Elliott Wave Theory to Rezolute Inc.Market Sentiment Report & AI Forecast for Swing Trade Picks - Newser
Chart overlay techniques for tracking Rezolute Inc.Portfolio Value Report & Intraday High Probability Setup Alerts - Newser
Should you hold or exit Rezolute Inc. nowJuly 2025 Market Mood & Safe Swing Trade Setups - Newser
Will Rezolute Inc. see short term momentumJuly 2025 Recap & AI Powered Buy and Sell Recommendations - Newser
What is the long term forecast for Rezolute Inc. stockJuly 2025 Final Week & Weekly Stock Breakout Alerts - خودرو بانک
Is it too late to sell Rezolute Inc.Long Setup & Free Technical Confirmation Trade Alerts - Newser
Candlestick Signal Suggests Reversal in Rezolute Inc.2025 Volume Leaders & High Conviction Investment Ideas - Newser
Leading vs lagging indicators on Rezolute Inc. performanceQuarterly Trade Summary & Capital Efficiency Focused Ideas - Newser
Does Rezolute Inc. qualify in momentum factor screeningJuly 2025 News Drivers & Risk Adjusted Buy/Sell Alerts - Newser
Rezolute Reaches Alignment With FDA on Phase 3 Ersodetug Trial in Tumor Hyperinsulinism - MarketScreener
Rezolute announces alignment with FDA on streamlined design for ongoing phase 3 trial of ersodetug in tumor hyperinsulinism - MarketScreener
Rezolute Announces Alignment with FDA on Streamlined Design for Ongoing Phase 3 Trial of Ersodetug in Tumor Hyperinsulinism - The Manila Times
Rezolute Aligns with FDA on Phase 3 Trial Design - TipRanks
Rezolute Announces FDA Alignment for Ersodetug Phase 3 Trial in Tumor HI. - AInvest
Rezolute Inc (RZLT) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.40%
자본화:
|
볼륨(24시간):